Due to the continuing evolution of SARS-CoV-2, the formation of new variants is not a novelty or a sporadic case, but it is a certainty that periodically recurs.1 One of the most recent variants is represented by the subvariant BA.2.75, also known as Centaurus. In comparison to the BA.2 variant, BA.2.75 carries nine additional mutations in the sequence of the spike protein genes: K147E, W152R, F157L, I210V, G257S G339H, G446S, N460K, and R493Q. The site G446S has been indicated as the site of potential escape from antibodies evoked by current vaccines that are capable of neutralizing Omicron 52 and it has been hypothesized that the BA.2.75 spike significantly reduces sensitivity toward therapeutic monoclonal antibodies than BA.5 (and thus than BA.2 and BA.4).

On the SARS-CoV-2 BA.2.75 variant: A genetic and structural point of view / Scarpa, F; Sanna, D; Azzena, I; Giovanetti, M; Benvenuto, D; Angeletti, S; Ceccarelli, G; Pascarella, S; Casu, M; Fiori, Pl; Ciccozzi, M. - In: JOURNAL OF MEDICAL VIROLOGY. - ISSN 0146-6615. - (2022), pp. 1-4. [10.1002/jmv.28119]

On the SARS-CoV-2 BA.2.75 variant: A genetic and structural point of view

Ceccarelli, G;Pascarella, S;
2022

Abstract

Due to the continuing evolution of SARS-CoV-2, the formation of new variants is not a novelty or a sporadic case, but it is a certainty that periodically recurs.1 One of the most recent variants is represented by the subvariant BA.2.75, also known as Centaurus. In comparison to the BA.2 variant, BA.2.75 carries nine additional mutations in the sequence of the spike protein genes: K147E, W152R, F157L, I210V, G257S G339H, G446S, N460K, and R493Q. The site G446S has been indicated as the site of potential escape from antibodies evoked by current vaccines that are capable of neutralizing Omicron 52 and it has been hypothesized that the BA.2.75 spike significantly reduces sensitivity toward therapeutic monoclonal antibodies than BA.5 (and thus than BA.2 and BA.4).
2022
BA.2.75; Phylogenomic; electrostatic potential
01 Pubblicazione su rivista::01f Lettera, Nota
On the SARS-CoV-2 BA.2.75 variant: A genetic and structural point of view / Scarpa, F; Sanna, D; Azzena, I; Giovanetti, M; Benvenuto, D; Angeletti, S; Ceccarelli, G; Pascarella, S; Casu, M; Fiori, Pl; Ciccozzi, M. - In: JOURNAL OF MEDICAL VIROLOGY. - ISSN 0146-6615. - (2022), pp. 1-4. [10.1002/jmv.28119]
File allegati a questo prodotto
File Dimensione Formato  
Scarpa_On the SARS‐CoV‐2_2022.pdf.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 1.13 MB
Formato Adobe PDF
1.13 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1654252
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 17
social impact